Shareholders’ Equity and Equity Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	$ 13,655	$ 4,723	$ 56,639	$ 13,666
Cost of Sales | Cost of services - Molecular profiling services
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	1,104	411	2,452	1,237
Cost of Sales | Cost of services - Pharma research and development services
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	17	3	20	6
Selling and marketing expense
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	3,322	1,092	6,554	3,177
General and administrative expense
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	6,410	2,148	39,438	6,147
Research and development expense
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation recognized	$ 2,802	$ 1,069	$ 8,175	$ 3,099